Under new prime minister Modi, India has launched the ambitious "Make in India"
campaign, with the clear aim to attract global companies to locate their
manufacturing resources in India. The timing of the campaign seems excellent, coinciding with global companies looking around for alternative manufacturing hubs to China. It could be just what India needs.
Although India hasn't really kept up with China's level of technology
investment for some time, the overall IPR legal framework in India is comprehensive and there's a strictly independent judiciary that Indians are rightly proud of. In recent
years, a rapidly growing number of patent cases in various fields have been handled by
Indian courts, continually further developing their specific competence on patents - arguably the most complex form of IPR - in the process. In fact, today India
even serves to demonstrate that major international patent enforcement is no longer restricted to the US and Europe. India was recently selected by Ericsson for the filing of cellular SEP infringement lawsuits against some alleged infringers, including the Chinese OEM Xiaomi and the Indian OEM Intex.
In relation to the Make in India campaign, the Indian Cellular Association (ICA), a grouping including many Indian mobile phone OEMs, recently submitted a report to the Indian government, apparently pertaining to IPR issues related to the campaign. Although the report is currently not public, statements from it have been quoted in a recent article in the Indian newspaper Economic Times. Sadly, those statements are at best confusing, and at worst misleading.
According to the article, ICA in its report seems to highlight the above-mentioned case of Ericsson enforcing its cellular SEP portfolio against alleged infringement in India, and then makes generalized, negative and far-reaching conclusions about India's future as a manufacturing hub based on that.
What seems to be a key message is:
"There can never be any manufacturing set up in India since the global
giants have cartelized and self declared their patents and they would be
charging these incredibly high rates only from the Indians and not from
the international companies."
To begin with, this statement presumes a clear link between manufacturing and patents. But with respect to cellular SEP licensing, the licensing point is at the OEM level, which is downstream from the manufacturing point. This makes the manufacturing territory virtually irrelevant. As far as cellular SEP licensing is concerned, for the typical Indian OEM selling products largely in India, it doesn't matter if the products are manufactured in India or not. So actually, the supposedly "showcase example" of SEP licensing highlighted in the report has nothing to do with Make in India in the first place.
There may well be other technology areas, for example pharmaceuticals, where IPR may be more coupled to manufacturing, but highlighting cellular SEP licensing in a manufacturing context is simply not relevant.
The allegation in the same quote that "global giants" would for some reason discriminate against Indians in particular with "incredibly high rates" is truly odd to say the least. Assuming still that the reference is cellular SEP licensing, it can have no basis in reality nor in common sense.
Firstly, it's highly questionable what rationale a licensor would have to even attempt such discrimination.
Secondly, there are FRAND commitments in place to prevent unfairness, unreasonableness and discrimination. Licensors' existing license databases are regularly scrutinized by
courts and agencies worldwide to ultimately enforce FRAND terms, including mitigating discrimination.
Thirdly, Indian OEMs are so far generally unlicensed under cellular SEPs, i.e. they pay zero actual royalties to SEP holders. So if anyone would be discriminated against, it's the already licensed international companies operating in India. And to add to the irony, the potential discriminators are Indian OEMs themselves, including members of ICA (!). Indeed, the High Court of Delhi in its recent infringement judgement in Ericsson vs. Intex found that Intex - an ICA member - had "acted in bad faith" and became an "unwilling licensee as per its overall conduct". It further decided on interim payments by Intex in the region of 0.8-1.3%, obviously a far cry from the alleged "incredibly high rates".
With regards to "global giants have cartelized and self-declared their patents", I'm afraid it's a bit of a challenge making any sense of the statement at all. The only feasible conclusion I can draw from it is that ICA has not fully understood the
simultaneously collaborative and competitive process of cellular
standards creation and the FRAND licensing regime for technology
sharing. It would be unfortunate if ICA failed to understand how these processes actually enable the
standards to be deployed worldwide and allow billions of dollars of R&D and network investments to be made and the entire related eco-system - which
ICA partly represents - to prosper.
Another key statement in the article reads:
"This in complete contrast to regimes such as China, where 0.019 per cent
royalty can be charged and USA, where the Courts have directed 0.5-2
per cent royalties to be charged on the value of smallest saleable
practicing unit which is royalty on chipset value and not on the phone
value"
In fact, the quoted examples of allegedly lower rates are not from particularly relevant rulings relating to cellular SEP licensing. The quoted China ruling is most likely from Huawei vs InterDigital in the Guangdong High Court of China. An early use of the Chinese Anti-Monopoly-Law (AML), it is widely seen as a purely political ruling against so-called Non-Practicing Entities (NPEs). If ICA really wanted to use China as a yardstick, a far more important measure would be the conclusion of the recent AML investigation against Qualcomm - importantly being a non-NPE and major cellular SEP licensor - where China allowed Qualcomm to charge a 3.25% royalty on the phone value.
Regarding the reference to the US and the "royalties to be charged on ...chipset value" argument, it is well-known to be nonsensical. In the US, chipset value has been squarely dismissed as a mandatory royalty base in e.g. CSIRO vs Cisco and by the US Federal Circuit in Ericsson vs. D-Link. Also in China it has been dismissed through the AML ruling on Qualcomm where phone value was maintained as royalty base. Based on e.g. such powerful international references, the High Court of Delhi also dismissed the argument in its recent judgement in the Ericsson vs. Intex case.
To the extent that ICA should be making recommendations concerning IPR, it should obviously strive to provide relevant, true and objective facts about IPR in the mobile industry, and their relevance - if any - to "Make in India". But in its report, ICA unfortunately does not do that. Instead it provides incorrect and irrelevant information about cellular SEP FRAND licensing in particular. I'm afraid I can't see how conclusions drawn from such information can be helpful to the government of India.
ICA is now, according to the same article, part of a Fast Track Task Force set up by the Indian government to rejuvenate mobile manufacturing in the country. To be clear, ICA may well be a competent advisor on many aspects of mobile phone manufacturing. But as far as cellular SEP licensing goes, as put recently by reputed IPR newspaper Intellectual Asset Management, "Perhaps FRAND matters are best left in the hands of the
judges".